Progesterone receptor gene polymorphism and risk for breast and ovarian cancer
1998

Progesterone Receptor Gene Polymorphism and Cancer Risk

Sample size: 265 publication Evidence: low

Author Information

Author(s): JM Lancaster, A Berchuck, ME Carney, R Wiseman, JA Taylor

Primary Institution: Duke University Medical Center

Hypothesis

Does the T2 allele of the progesterone receptor gene increase the risk for ovarian or breast cancer?

Conclusion

The study found no increased frequency of the T2 genotype in women with breast or ovarian cancer compared to control subjects.

Supporting Evidence

  • 24 out of 67 patients with ovarian cancer had the T2 allele, compared to 38 out of 184 control subjects.
  • The frequency of T2 genotypes in American control women is similar to that of pooled Irish/German control subjects.
  • The study observed no increased frequency of the T2 genotype among cases of breast or ovarian cancer.

Takeaway

The researchers looked at a gene that might be linked to breast and ovarian cancer but found that it doesn't seem to make women more likely to get these cancers.

Methodology

PCR-based assay was used to analyze leucocyte DNA from patients and control subjects.

Limitations

The study only included a specific population and may not be generalizable.

Participant Demographics

Caucasian North-American women, including patients with ovarian cancer, breast cancer, and non-cancer control subjects.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication